SARAH DEERING BARANSKI: Open Payments
NPI 1396818308 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 41 payments from 14 companies in 2025. Trend: 2023 $806 · 2024 $771 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $212 |
| QOL Medical, LLC | 4 | $111 |
| Janssen Biotech, Inc. | 1 | $109 |
| GENZYME CORPORATION | 4 | $88 |
| Madrigal Pharmaceuticals | 4 | $77 |
| Gilead Sciences, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
Products named: Sucraid, TREMFYA, CREON, DUPIXENT, REZDIFFRA, RINVOQ, OMVOH, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
